January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Five papers suggested by Arndt Vogel
Dec 24, 2024, 12:16

Five papers suggested by Arndt Vogel

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.

ESMO

He suggested following few must-read papers on X:

1. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Authors:  Rachna T. Shroff et al.

Five papers suggested by Arndt Vogel

Five papers suggested by Arndt Vogel

3. Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial

Authors: Laura A. Dawson et al.

Five papers suggested by Arndt Vogel

4. A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma

Authors: L. Goyal et al.

Five papers suggested by Arndt Vogel

5. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals

Authors: Amanda L. Blackford et al.

Five papers suggested by Arndt Vogel

More Posts Featuring Arndt Vogel.